NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions

Corona Virus InfectionCOVID-19SARSAcute Respiratory Distress Syndrome

Interventions

BIOLOGICAL

Zofin

Biological: Zofin will be administered intravenously with 1ml, containing 2-5 x 10\^11 particles/mL in addition to the Standard Care. The Zofin dose will be diluted in 100 mL of sterile saline at subject's bedside.

OTHER

Placebo

Other: Placebo Placebo (saline) will be administered intravenously with 1ml in addition to the Standard Care. The Placebo dose will be diluted in 100 mL of sterile saline at subject's bedside.

Trial Locations (1)

10604

George C. Shapiro, New York

All Listed Sponsors

lead

ZEO ScientifiX, Inc.

INDUSTRY